TruBridge Faces Securities Investigation, Adding Legal Risk to Already Stretched Valuation

What happened

The Rosen Law Firm announced an investigation into TruBridge for potentially issuing misleading business information, adding litigation risk to the company's narrative. TruBridge has been executing better recently, with 94% recurring revenue and positive free cash flow, but the stock already trades at a premium 13x EV/EBITDA. The company's balance sheet remains strained with net debt/EBITDA of 4.65x and restrictive credit covenants, and internal control weaknesses persisted into mid-2024. Bookings declined year-over-year in Q3 2025, and the company is guiding for steady but not accelerating performance. The securities investigation could amplify risks from existing operational and financial strains, making the stock less attractive at current levels.

Implication

The investigation adds a new risk dimension to a company that already carried elevated leverage, control weaknesses, and full valuation. While the underlying RCM business has secular tailwinds, the combination of legal overhang and limited near-term upside catalysts suggests waiting for a better risk/reward entry point, such as clearer deleveraging, control remediation, or a cheaper stock price.

Thesis delta

The investigation shifts the risk profile from purely operational/financial to include potential legal liability and reputational damage. Previously, the thesis focused on operational improvements and guidance delivery; now, legal outcomes could impair cash flows, delay deleveraging, and pressure management bandwidth. The probability of a negative outcome has increased, warranting a higher risk premium and reinforcing the WAIT stance.